| 名称
|
(Arg8)-Vasotocin
|
| 编码
|
[113-80-4]
|
| 别名
|
(Arg8)-Vasotocin
|
| 纯度
|
80%，90%，95%，98%，99%
|
| 重量
|
1mg,5mg,10mg,50mg,100mg,1g
|
| 序列（单字母缩写）
|
CYIQNCPRG-NH2?(Cys & Cys bridge)
|
| 序列（三字母缩写）
|
H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2?(trifluoroacetate salt)(Disulfide bond)
|
| 基本描述
|
This peptide is tumor suppressor protein, p53 (368-393). There is a biotinylated lyine followed by a GG linker at the N-terminal and an acetylated lysine at lysine 373. Activation of the p53 protein results in the transcription of antiproliferative proteins and induction of apoptosis. The p53 tumor suppressor is a principal mediator of growth arrest, senescence, and apoptosis in response to a broad array of cellular damage.
|
| 溶解度
|
|
| 分子量
|
1050.23
|
| 化学式
|
C43H67N15O12S2
|
| 存储条件
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| 注释
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
F.L.Moore and C.A.Lowry, Comp. Biochem. Physiol. C, Pharmacol. Toxicol. Endocrinol., 119, 251 (1998)
A.Jurkevich and R.Grossmann, Domest. Anim. Endcrinol., 25, 93 (2003)
F.Toyoda et al., Horm. Behav., 44, 346 (2003)
R.J.Balment et al., Gen. Comp. Endocrinol., 147, 9 (2006)
|
| C端
|
|
| N端
|
|
| 化学桥
|
(Cys1 and 6 bridge)
|